TrialJapanese journal of clinical oncology2015

A randomized Phase III trial of weekly or 3-weekly doses of nab-paclitaxel versus weekly doses of Cremophor-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE Trial).

Wasaburo Koizumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.